EU Poised To Take Lead On In Silico Clinical Trials For Medtech And Pharma
This article was originally published in Clinica
Executive Summary
The European Commission will shortly be asked to consider investing at least 200m Euros over the next four years in initiatives that will pave the way for the adoption of in silico (computer simulation) technologies in clinical trials of medical devices and medicines.